RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Takashi Matsui to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Takashi Matsui has written about Drug Resistance, Neoplasm.
Takashi Matsui
Connection Strength
0.142
Drug Resistance, Neoplasm
  1. Oya Y, Yoshida T, Asada K, Oguri T, Inui N, Morikawa S, Ito K, Kimura T, Kunii E, Matsui T, Kubo A, Kato T, Abe T, Tsuda T, Hida T. Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib. BMC Cancer. 2021 Jan 12; 21(1):57.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support